15.7
Ensysce Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
5.30
FY23:
2.29
FY24:
5.34
FY25:
7.24
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.75
FY22:
0.59
FY23:
0.42
FY24:
0.25
FY25:
0.21
Total assets
Change from FY21 to FY25
millions USD
FY21:
16.4
FY22:
5.89
FY23:
2.71
FY24:
5.60
FY25:
7.45
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.5
FY22:
9.46
FY23:
3.33
FY24:
2.21
FY25:
4.57
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.09
FY22:
0.45
FY23:
0.03
FY24:
0.01
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.88
FY22:
−3.71
FY23:
−0.32
FY24:
3.71
FY25:
3.21
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
16.7
FY22:
6.20
FY23:
3.04
FY24:
5.93
FY25:
7.78
All amounts in millions USD